ANDA Sponsors Swarm On Vimpat Blockbuster As Protection Expires
Amneal, Glenmark, and Sun Pharma Among Firms With ANDA Approvals
UCB’s Vimpat blockbuster has finally fallen to generic competition in the US, after its intellectual property was skewered by ANDA sponsors as part of a failed challenge before the US Supreme Court in 2018 and 2019.
